Full Year Report 2021

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company’s Full Year Report for January – December 2021 on Thursday, February 3, 2022, at 08:00 a.m. CET.

Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Neurodegenerative disorders

BioArctic is committed to help people with neurodegenerative disorders

Proud partner of: